Saksena S - Search Results

1

Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group.

Pacifico A, Hohnloser SH, Williams JH, Tao B, Saksena S, Henry PD, Prystowsky EN. Pacifico A, et al. Among authors: saksena s. N Engl J Med. 1999 Jun 17;340(24):1855-62. doi: 10.1056/NEJM199906173402402. N Engl J Med. 1999. PMID: 10369848 Free article. Clinical Trial.

2

Survival of implantable cardioverter-defibrillator recipients: role of left ventricular function and its relationship to device use.

Mehta D, Saksena S, Krol RB. Mehta D, et al. Among authors: saksena s. Am Heart J. 1992 Dec;124(6):1608-14. doi: 10.1016/0002-8703(92)90080-f. Am Heart J. 1992. PMID: 1462921 Review.

3

Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.

Saksena S, Poczobutt-Johanos M, Castle LW, Fogoros RN, Alpert BL, Kron J, Pacifico A, Griffin J, Ruskin JN, Kehoe RF, et al. Saksena S, et al. J Am Coll Cardiol. 1992 Mar 1;19(3):490-9. doi: 10.1016/s0735-1097(10)80260-8. J Am Coll Cardiol. 1992. PMID: 1537999 Clinical Trial.

4

Prophylactic implantable cardioverter defibrillator therapy in high-risk patients with coronary artery disease.

Kolettis TM, Saksena S. Kolettis TM, et al. Among authors: saksena s. Am Heart J. 1994 Apr;127(4 Pt 2):1164-70. doi: 10.1016/0002-8703(94)90105-8. Am Heart J. 1994. PMID: 7909188 Review.

5

The impact of implantable cardioverter defibrillator therapy on health care systems.

Saksena S. Saksena S. Am Heart J. 1994 Apr;127(4 Pt 2):1193-200. doi: 10.1016/0002-8703(94)90109-0. Am Heart J. 1994. PMID: 8160600 Review.

6

Implanted cardioverter-defibrillators are preferable to drugs as primary therapy in sustained ventricular tachyarrhythmias.

Saksena S, Madan N, Lewis C. Saksena S, et al. Prog Cardiovasc Dis. 1996 May-Jun;38(6):445-54. doi: 10.1016/s0033-0620(96)80008-9. Prog Cardiovasc Dis. 1996. PMID: 8638025 Review.

7

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Moss AJ, et al. Among authors: saksena s. N Engl J Med. 1996 Dec 26;335(26):1933-40. doi: 10.1056/NEJM199612263352601. N Engl J Med. 1996. PMID: 8960472 Free article. Clinical Trial.

8

Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.

Neglia JJ, Krol RB, Giorgberidze I, Mathew P, Lewis C, Munsif AN, Saksena S. Neglia JJ, et al. Among authors: saksena s. J Interv Card Electrophysiol. 1997 Feb;1(1):49-56. doi: 10.1023/a:1009766718942. J Interv Card Electrophysiol. 1997. PMID: 9869951

9

Third- and fourth-generation implantable cardioverter defibrillators: current status and future development.

Saksena S, Diaz ML, Varanasi S, Mathew P, Berg J, Krol RB, Kaushik RR. Saksena S, et al. J Interv Cardiol. 1994 Oct;7(5):427-40. doi: 10.1111/j.1540-8183.1994.tb00480.x. J Interv Cardiol. 1994. PMID: 10155192

10

Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems?

Pratt CM, Camm AJ, Bigger JT Jr, Breithardt G, Campbell RW, Epstein AE, Kappenberger LJ, Kuck KH, Pocock S, Saksena S, Waldo AL. Pratt CM, et al. Among authors: saksena s. J Cardiovasc Electrophysiol. 1999 Nov;10(11):1534-49. doi: 10.1111/j.1540-8167.1999.tb00212.x. J Cardiovasc Electrophysiol. 1999. PMID: 10571373 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

624 results

Search Page